Table 5 Stronger association of SJC with high than with low levels of ACarPA^a.

Measure	1st level ^b	2nd level	β	SE	p value
DAS28-ESR	neg	low	0.15	0.03	1.4 × 10^–5
	neg	high	0.16	0.03	4.0 × 10^–6
	low	high	0.06	0.06	0.29
CDAI	neg	low	0.13	0.03	2.6 × 10^–4
	neg	high	0.15	0.04	6.3 × 10^–5
	low	high	0.06	0.06	0.36
HUPI	neg	low	0.15	0.03	1.1 × 10^–5
	neg	high	0.15	0.04	1.9 × 10^–5
	low	high	0.05	0.06	0.43
SJC	neg	low	0.12	0.03	2.9 × 10^–4
	neg	high	0.18	0.03	1.8 × 10^–7
	low	high	0.13	0.06	0.030
TJC	neg	low	0.13	0.03	1.8 × 10^–4
	neg	high	0.13	0.04	1.9 × 10^–4
	low	high	0.04	0.06	0.46
PtGA	neg	low	0.09	0.03	0.0081
	neg	high	0.06	0.04	0.097
	low	high	0.06	0.03	0.065
ESR	neg	low	0.09	0.03	0.0050
	neg	high	0.11	0.04	0.0024
	low	high	0.05	0.06	0.39
HAQ	neg	low	0.06	0.03	0.10
	neg	high	0.10	0.04	0.0048
	low	high	0.08	0.06	0.18
Pain VAS	neg	low	0.06	0.03	0.065
	neg	high	0.07	0.04	0.053
	low	high	0.02	0.06	0.69
PhGA	neg	low	0.17	0.03	1.0 × 10^–6
	neg	high	0.14	0.04	2.4 × 10^–4
	low	high	0.00	0.06	0.96

^aData from 974 to 978 patients were available for analyses except 902 for CDAI, 949 for HAQ, 966 for Pain VAS, and 903 for PhGA.
^bThe slope coefficients (β) with their standard errors (SE), and p values corresponding to the three specified comparisons in the unadjusted analysis are presented. The cut-off between low and high positive ACarPA was 3× the upper limit of normal.

Quick links

Search